IMCAS Academy

Introduction
Evaluation
Program
Speakers
Sponsor list
Accreditation

IMCAS Asia 2024
Program

FOCUS ON 015

REGENBOGEN CO., LTD. Symposium - Next-level insights into Exosome therapy

Room: Room 3 - Level 2
Date: Friday 21 June 2024 at 12:00 to 13:00
Format: INDUSTRY SYMPOSIUM > educational and promotional program conducted by the supporting company

Lectures of the session

Hours	Speakers	Lecture title	Abstract	Number
12:00	Dr Wachira KUNATHATHORN	Introduction		138538
12:05	Dr Seong Jae YOUN	The cutting-edge treatment including exosome and collagen therapies for anti-aging		138539
12:30	Dr Wichai HONGCHARU	Exosome drug delivery for DEJ junction		138540
12:50		Q & A		138541

Go to previous session

Go to next session

Dr Wachira KUNATHATHORN

Dermatologist

Thailand

Other author(s) :

Introduction

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Seong Jae YOUN

Dermatologist

South Korea

Other author(s) :

The cutting-edge treatment including exosome and collagen therapies for anti-aging

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Dr Wichai HONGCHARU

Dermatologist

Thailand

Other author(s) :

Exosome drug delivery for DEJ junction

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Q & A

You have a question?

Quickly find your answer in our FAQ

Congresses

IMCAS World Congress
IMCAS Americas
IMCAS Asia
IMCAS China

About

Company
Privacy Policy
Legal information

Academy

Home
Courses
Webinars
Explore
Blog

Grant

Educational grant

Get in touch

Username/Email

Password

Keep me logged in

Forgot password ? Do not have an account yet? Sign up now

Keep me logged in

academy.Do_not_have_an_account_yet Sign up now

IMCAS Asia 2024 Program

FOCUS ON 015

REGENBOGEN CO., LTD. Symposium - Next-level insights into Exosome therapy

Lectures of the session

IMCAS Asia 2024
Program